Sign inJoin waitlistJoin the waitlist

Douglas Tyler

Associate Chair of Community Operations & Strategy · University of North Carolina Hospitals

Credentials: · · · · ·

History

Community Operations & Strategy · University of North Carolina Hospitals
Present
University of North Carolina Hospitals
Present
University of North Carolina Hospitals
Present

Complex General Surgical Oncology
University of Texas at Austin, 2019-2020
2019–2020
Surgery
Duke University Hospital
1987–1992
Allergy and Immunology
Duke University Hospital
1985–1992
University of Texas at Austin, 2019-2020
Geisel School of Medicine at Dartmouth
1981–1985

Research

Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients
Annals of Surgery · 2014 · 334 citations
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines
Review · Journal of the National Comprehensive Cancer Network · 2007 · 328 citations
Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA
Gastrointestinal Endoscopy · 2003 · 300 citations

Georgia Beasley
58 papers
Theodore Pappas
38 papers
Bryan Clary
33 papers · 6 as a resident
SP
Scott Pruitt
33 papers
Rebekah White
29 papers · 15 as a resident
Hilliard Seigler
28 papers
Paul Mosca
28 papers
Brian Czito
23 papers
Michael Morse
22 papers
PS
Paul Speicher
22 papers · 22 as a resident
HH
Herbert Hurwitz
21 papers
Mark Onaitis
21 papers · 21 as a resident

Grants

Regional Melanoma Chemotherapy: A Novel Way to Augment Systemic Immunotherapy
Department of Veterans Affairs · I01
Contact PI · Durham Va Medical Center
2015–2016
Adaptor Proteins and Malignant Transformation
National Cancer Institute · K08
Contact PI · $329.2K · Duke University
1998–2002

Clinical trials

Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma
Principal investigator · Completed · Phase 1
Duke University
2014–2015
EF5 in Melanoma Patients
Principal investigator · Completed · Phase 1
Douglas Tyler
2012–2014
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
Principal investigator · Completed · Phase 1
Douglas Tyler
2010–2014
A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma
Principal investigator · Withdrawn · Phase 1
Duke University
2008